How to boost enrollment of Black, Hispanic patients in pediatric clinical trials
While Black and Hispanic families are enthusiastic about research participation, other provider- and system-focused factors may influence their involvement in pediatric oncology clinical trials, a UT Southwestern Medical Center-led study found. The findings, published in JAMA Network Open, focused on parent and clinician perspectives, revealing opportunities to increase clinical trial…
A recent study led by UT Southwestern Medical Center has shed light on the factors influencing Black and Hispanic families' participation in pediatric oncology clinical trials. The findings, published in JAMA Network Open, suggest that while these families are highly enthusiastic about research participation, provider- and system-level factors may be hindering their involvement.
Lead author, Dr. Puja Umaretiya, emphasizes the importance of addressing these barriers to improve equitable participation and better outcomes for historically marginalized patients. The study highlights the need to reduce clinician gatekeeping, simplify informed consent discussions, and provide accessible trial materials, particularly for families with limited English proficiency.
Additionally, efforts should be made to support families facing material hardship, ensuring they receive the necessary resources to successfully participate in clinical trials.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
